A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC

Clinical trial NCT02378870 · TERMINATED

Trial details

NCT number: NCT02378870
Sponsor: DexTech Medical AB
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2015-01-01
Primary completion: 2015-06-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.